Uncompensated care was supposed to be a thing of the past, but it's persisting in many states not expanding Medicaid eligibility. As an alternative, for some high-cost uninsured patients, hospitals are turning to a new option.
Uncompensated care was supposed to be a thing of the past, but it's persisting in many states not expanding Medicaid eligibility. As an alternative, for some high-cost uninsured patients, hospitals are turning to a new option.
In his 32 years working in insurance operations at Forrest General Hospital in Hattiesburg, Mississippi, Pat Riley has seen the problem of uninsured patients ebb and flow — with poor health outcomes for individuals and uncompensated costs for the health system — and the Great Recession brought another surge.
Now director of insurance at Forrest General, the 512-bed flagship of Forrest Health, Riley is optimistic about the potential of the Affordable Care Act. While Mississippi, like 23 other states, isn’t expanding Medicaid eligibility to low-income childless adults, those earning above 100 percent of the federal poverty level can get premium and cost-sharing subsidies for exchange plans — a message that Riley and Forrest Health try to hammer home to the residents of greater Hattiesburg through participation in health fairs, town halls, public service announcements and outreach to patients.
Read the full story here: http://bit.ly/1rRjunI
Source: Healthcare Payer News
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
High Drug Costs, PBM Reform, and Access Challenges Take Center Stage at AMCP 2025
March 25th 2025As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, the upcoming AMCP annual meeting will provide critical insights into legislative impacts, drug affordability, formulary design, and emerging treatment trends.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
High Drug Costs, PBM Reform, and Access Challenges Take Center Stage at AMCP 2025
March 25th 2025As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, the upcoming AMCP annual meeting will provide critical insights into legislative impacts, drug affordability, formulary design, and emerging treatment trends.
Read More
2 Commerce Drive
Cranbury, NJ 08512